Use of Sodium–Glucose Cotransporter 2 (SGLT-2) Inhibitors Beyond Diabetes: On the Verge of a Paradigm Shift?. Rhythmos. 2020;15(1):1-5. Accessed May 3, 2025. https://www.rhythmos.gr/index.php/Rhythmos/article/view/473